February 2, 2026
admin-ajax
Morning Rounds Writer and Reporter

Good morning. No, I haven't dug my car out yet. No, I'm not planning on going anywhere. Yes, it's cold. No, the cat is fine. You?

pharma

Can a decades-old drug treat Alzheimer’s?

Money, brains, and pills float around the BMS building in this green-tinted collage

Illustration: Camille MacMillin/STAT; Photos: Adobe

Bristol Myers Squibb is betting yes. Later this year, the company will get the results from three pivotal studies on a pill that was first developed in the ’90s — before the DVD was invented, as STAT’s Damian Garde notes agedly. Bristol needs this one to be a blockbuster, as some of its biggest drugs will lose patent protection before the end of the decade. But Wall Street has some reservations. 

“Take a step back: It’s crazy to think we’re looking at a trial from the ’90s as a comp for something in 2026,” pharma analyst Evan Seigerman told Damian. “That’s the scary part.”

But people who know the drug’s origin story might say success has been a long time coming. Read more from Damian on the decades-long journey that got the pill to Bristol. It involves a not-small amount of vomiting, a guy whose “one good idea in [his] life” was how to stop all the vomiting, and eventually, a Bristol CEO ready to go shopping.


education

What’s in a word? Sometimes, $200,000

The Department of Education proposed a rule Friday that would limit how large a federal loan a graduate student can take out based on whether they’re a “professional” student or not. Those pursuing professional degrees will, under the new rule, be allowed a $200,000 borrowing limit, while the rest will be capped at $100,000. Students pursuing degrees in public health, nursing, social work, and those working to become physician assistants, physical therapists, and more were excluded from the professional category. Pharmacy, dentistry, veterinary, medical, chiropractic, and podiatry degrees, among others, are considered professional.

The changes were first put forth in Trump’s tax-cut bill, passed last summer. There will be a 30-day comment period and, if finalized, the rule will go into effect July 1. Workers in demoted fields worry about the impact this change will have on the future of the workforce. “It’ll be the next emergency, the next pandemic, where we won’t have enough people who are fully trained to be able to take on the challenges of public health,” Boris D. Lushniak, dean of University of Maryland’s public health school said at a press conference. 

As federal research grants are still in limbo, the change means institutions are “being squeezed from both sides,” added Hilary Godwin, dean of the University of Washington’s public health school. Schools may need to find ways to fundraise in the private sector to support students, she said.



men & boys

We’re getting closer to male birth control. Men are excited

An illustration of a hand wearing a pink sleeve and pink nails hands a pack of birth control pills to an outstretched hand wearing a blue sleeve.

Maria Fabrizo for STAT 

If a cisgender man wants to get on birth control, his only real option is to put on a condom. That, or get or a vasectomy: a surgical procedure to cut the tube that allows sperm to enter semen. These are the same options that have been around since the 1800s. Condoms have user failure rates up to 16%, and vasectomies are an expensive commitment. Luckily — and finally — the options may soon expand. 

There is a robust pipeline of male birth control products being tested. If trials are successful, three of them could potentially commercialize in a few years. “We are receiving emails from men all over the world asking to participate” in trials, said Nadja Mannowetz, the co-founder of a San Francisco company conducting trials for a male birth control pill. 

Read more from STAT’s Annalisa Merelli about why men want birth control options, what side effects they’re willing to put up with, and how we got here from the early days of “testicular bathing.” 


public health

Some actually good infectious disease news

The Guinea worm eradication program is inching closer to completion, with a mere 10 cases of the debilitating illness reported in 2025, the Carter Center announced on Friday. The center, established by the late President Jimmy Carter, has been the lead player in the effort to rid the world of the parasitic worms that cause this horrific illness. The 2025 cases occurred in South Sudan, Chad, and Ethiopia. In 2024, there were 15 cases recorded.

When the eradication program began in 1986, about 3.5 million people in 21 countries were infected each year with Guinea worms, typically acquired through drinking contaminated water. After developing in a human host, a Guinea worm will burrow its way out of its host's body, causing severe pain as it does. People often submerse themselves in water to ease their suffering, allowing the worm to release larva that then infect others. It’s estimated that the eradication effort has averted 100 million cases of the disease. To date, the only other human disease ever eradicated was the virus that caused smallpox. — Helen Branswell


first opinion

Losing a century of public health progress

Earlier this month, the EPA announced it would no longer calculate the economic benefits of lives saved when setting limits on fine particulate matter and ozone. For more than 50 years, the federal agency has used a metric called the “value of statistical life” to weigh the benefits of clean air against the costs of regulation. The agency’s own math has shown that for every dollar spent reducing fine particulate pollution, we get back as much as $77 in health benefits.

“What is the value of a human life?” epidemiologist Michelle Williams writes in a new First Opinion essay. “According to the Trump administration’s Environmental Protection Agency, the answer is zero dollars.” Read more on what’s at stake.


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • Scientists finally may know why kidney patients die of heart disease, Washington Post

  • How much should psychedelics researchers disclose about their personal use? STAT
  • To set a world record at 81, all she had to do was hold on, New York Times
  • Newsom files a civil rights complaint against CMS’ Oz in latest feud with the Trump administration, STAT

Thanks for reading! More next time,